PF-477736
98%
- Product Code: 224801
Alias:
(alphaR)-alpha-amino-N-(5,6-dihydro-2-(1-methyl-1H-pyrazole-4-yl)-6-oxo-1H-pyrrolo(4,3,2-ef)(2,3)benzodiazepine-8-yl)cyclohexaneacetamide
CAS:
952021-60-2
| Molecular Weight: | 419.48 g./mol | Molecular Formula: | C₂₂H₂₅N₇O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16038847 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
PF-477736 is a potent and selective inhibitor of checkpoint kinase 1 (Chk1), a key protein involved in the DNA damage response pathway. Its primary application lies in cancer research, particularly in enhancing the effectiveness of DNA-damaging chemotherapeutic agents. By inhibiting Chk1, PF-477736 prevents cancer cells from arresting the cell cycle to repair DNA damage, thereby promoting cell death when used in combination with agents like gemcitabine, cisplatin, or radiation.
It has been widely used in preclinical studies to investigate synthetic lethality and to overcome chemoresistance in tumor cells, especially in cancers with p53 deficiencies where the G1 checkpoint is impaired and cells rely more heavily on Chk1-mediated S and G2 checkpoints. This makes PF-477736 a valuable tool in developing targeted combination therapies aimed at increasing tumor sensitivity while sparing normal tissues.
Due to its role in abrogating cell cycle arrest, it is also employed in mechanistic studies to dissect DNA damage signaling pathways and to validate Chk1 as a therapeutic target in oncology.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿7,660.00 |
+
-
|
PF-477736
PF-477736 is a potent and selective inhibitor of checkpoint kinase 1 (Chk1), a key protein involved in the DNA damage response pathway. Its primary application lies in cancer research, particularly in enhancing the effectiveness of DNA-damaging chemotherapeutic agents. By inhibiting Chk1, PF-477736 prevents cancer cells from arresting the cell cycle to repair DNA damage, thereby promoting cell death when used in combination with agents like gemcitabine, cisplatin, or radiation.
It has been widely used in preclinical studies to investigate synthetic lethality and to overcome chemoresistance in tumor cells, especially in cancers with p53 deficiencies where the G1 checkpoint is impaired and cells rely more heavily on Chk1-mediated S and G2 checkpoints. This makes PF-477736 a valuable tool in developing targeted combination therapies aimed at increasing tumor sensitivity while sparing normal tissues.
Due to its role in abrogating cell cycle arrest, it is also employed in mechanistic studies to dissect DNA damage signaling pathways and to validate Chk1 as a therapeutic target in oncology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :